BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 22767216)

  • 41. A TRAIL-Delivered Lipoprotein-Bioinspired Nanovector Engineering Stem Cell-Based Platform for Inhibition of Lung Metastasis of Melanoma.
    Chen K; Cao X; Li M; Su Y; Li H; Xie M; Zhang Z; Gao H; Xu X; Han Y; Zhou J; Wang W
    Theranostics; 2019; 9(10):2984-2998. PubMed ID: 31244937
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Proliferation and differentiation characteristics of human bone marrow mesenchymal stem cells during ex-vivo expansion].
    Hu JB; Zhou Y; Jiang DD; Tan WS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):7-10. PubMed ID: 16388733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma.
    Choi SA; Hwang SK; Wang KC; Cho BK; Phi JH; Lee JY; Jung HW; Lee DH; Kim SK
    Neuro Oncol; 2011 Jan; 13(1):61-9. PubMed ID: 21062796
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adventage of mesenchymal stem cells (MSC) expansion directly from purified bone marrow CD105+ and CD271+ cells.
    Jarocha D; Lukasiewicz E; Majka M
    Folia Histochem Cytobiol; 2008; 46(3):307-14. PubMed ID: 19056534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TRAIL delivered by mesenchymal stromal/stem cells counteracts tumor development in orthotopic Ewing sarcoma models.
    Guiho R; Biteau K; Grisendi G; Taurelle J; Chatelais M; Gantier M; Heymann D; Dominici M; Redini F
    Int J Cancer; 2016 Dec; 139(12):2802-2811. PubMed ID: 27558972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of CD24 as a marker to rapidly define the mesenchymal stem cell phenotype and its differentiation in human nucleus pulposus.
    Guan X; Ma X; Zhang L; Feng H; Ma Z
    Chin Med J (Engl); 2014; 127(8):1474-81. PubMed ID: 24762592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy.
    Grisendi G; Bussolari R; Cafarelli L; Petak I; Rasini V; Veronesi E; De Santis G; Spano C; Tagliazzucchi M; Barti-Juhasz H; Scarabelli L; Bambi F; Frassoldati A; Rossi G; Casali C; Morandi U; Horwitz EM; Paolucci P; Conte P; Dominici M
    Cancer Res; 2010 May; 70(9):3718-29. PubMed ID: 20388793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.
    Haselmann V; Kurz A; Bertsch U; Hübner S; Olempska-Müller M; Fritsch J; Häsler R; Pickl A; Fritsche H; Annewanter F; Engler C; Fleig B; Bernt A; Röder C; Schmidt H; Gelhaus C; Hauser C; Egberts JH; Heneweer C; Rohde AM; Böger C; Knippschild U; Röcken C; Adam D; Walczak H; Schütze S; Janssen O; Wulczyn FG; Wajant H; Kalthoff H; Trauzold A
    Gastroenterology; 2014 Jan; 146(1):278-90. PubMed ID: 24120475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A modified method to isolate and identify the adult mesenchymal stem cells from human bone marrow].
    Wu JY; Liao C; Xu ZP; Chen JS; Gu SL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):557-60. PubMed ID: 16800942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complete regression of metastatic renal cell carcinoma by multiple injections of engineered mesenchymal stem cells expressing dodecameric TRAIL and HSV-TK.
    Kim SW; Kim SJ; Park SH; Yang HG; Kang MC; Choi YW; Kim SM; Jeun SS; Sung YC
    Clin Cancer Res; 2013 Jan; 19(2):415-27. PubMed ID: 23204131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stem cell-based gene therapy activated using magnetic hyperthermia to enhance the treatment of cancer.
    Yin PT; Shah S; Pasquale NJ; Garbuzenko OB; Minko T; Lee KB
    Biomaterials; 2016 Mar; 81():46-57. PubMed ID: 26720500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TRAIL Promotes Tumor Growth in a Syngeneic Murine Orthotopic Pancreatic Cancer Model and Affects the Host Immune Response.
    Beyer K; Normann L; Sendler M; Käding A; Heidecke CD; Partecke LI; von Bernstorff W
    Pancreas; 2016 Mar; 45(3):401-8. PubMed ID: 26390425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis.
    Hinz S; Trauzold A; Boenicke L; Sandberg C; Beckmann S; Bayer E; Walczak H; Kalthoff H; Ungefroren H
    Oncogene; 2000 Nov; 19(48):5477-86. PubMed ID: 11114725
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decoy TRAIL receptor CD264: a cell surface marker of cellular aging for human bone marrow-derived mesenchymal stem cells.
    Madsen SD; Russell KC; Tucker HA; Glowacki J; Bunnell BA; O'Connor KC
    Stem Cell Res Ther; 2017 Sep; 8(1):201. PubMed ID: 28962588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Irradiation enhances susceptibility of tumor cells to the antitumor effects of TNF-α activated adipose derived mesenchymal stem cells in breast cancer model.
    Mohammadpour H; Pourfathollah AA; Nikougoftar Zarif M; Shahbazfar AA
    Sci Rep; 2016 Jun; 6():28433. PubMed ID: 27329316
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
    Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
    Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells.
    Festuccia C; Gravina GL; D'Alessandro AM; Millimaggi D; Di Rocco C; Dolo V; Ricevuto E; Vicentini C; Bologna M
    Int J Oncol; 2008 Aug; 33(2):381-8. PubMed ID: 18636160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas.
    Grisendi G; Spano C; D'souza N; Rasini V; Veronesi E; Prapa M; Petrachi T; Piccinno S; Rossignoli F; Burns JS; Fiorcari S; Granchi D; Baldini N; Horwitz EM; Guarneri V; Conte P; Paolucci P; Dominici M
    Stem Cells; 2015 Mar; 33(3):859-69. PubMed ID: 25420617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human umbilical cord mesenchymal stem cells delivering sTRAIL home to lung cancer mediated by MCP-1/CCR2 axis and exhibit antitumor effects.
    Yan C; Song X; Yu W; Wei F; Li H; Lv M; Zhang X; Ren X
    Tumour Biol; 2016 Jun; 37(6):8425-35. PubMed ID: 26733169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.